J2513 HCPCS code: Injection, pentastarch, 10% solution, 100 ml
J2513 is the HCPCS Level II code for injection, pentastarch, 10% solution, 100 ml. CMS terminated J2513 on 2025-12-31; do not bill it for later dates of service. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2006-01-01 |
| Last action effective | 2026-01-01 |
| Terminated | 2025-12-31 |
What changed for J2513
- 2006-01-01: J2513 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2513?
J2513 is the HCPCS Level II code for injection, pentastarch, 10% solution, 100 ml. Short descriptor: "Pentastarch 10% solution".
Does Medicare cover J2513?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
Related J25 codes
- J2501 — Injection, paricalcitol, 1 mcg
- J2502 — Injection, pasireotide long acting, 1 mg
- J2503 — Injection, pegaptanib sodium, 0.3 mg
- J2504 — Injection, pegademase bovine, 25 iu
- J2505 — Injection, pegfilgrastim, 6 mg
- J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- J2507 — Injection, pegloticase, 1 mg
- J2508 — Injection, pegunigalsidase alfa-iwxj, 1 mg
- J2510 — Injection, penicillin g procaine, aqueous, up to 600,000 units
- J2515 — Injection, pentobarbital sodium, per 50 mg
- J2516 — Injection, pentamidine isethionate, 1 mg
- J2540 — Injection, penicillin g potassium, up to 600,000 units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2513
- Watch J2513 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2513
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.